REDCARE PHARMACY NV
Commented by Stefan Feulner on April 10th, 2026 | 07:05 CEST
Strategy, Aspermont, Redcare Pharmacy – Turnaround Opportunities Back in Focus
Markets are increasingly pricing in comeback potential. While the largest cryptocurrency climbs back above USD 70,000 and institutional inflows provide a tailwind, some players are unwaveringly betting on expansion despite billions in losses. At the same time, a data-driven platform model in the commodities sector is gaining traction, with over 180% upside potential, driven by scalable revenues and growing demand. In the e-commerce healthcare market, too, an operational turnaround following a prolonged period of weakness is triggering double-digit price movements. The combination of turnaround dynamics, oversold valuations, and long-term growth drivers could set the stage for further upside.
ReadCommented by Fabian Lorenz on August 30th, 2023 | 08:30 CEST
Better than Nel & Co.? Megatrend shares Redcare Pharmacy and Cantourage Group recommended as buy
Hydrogen has electrified investors for years. But pure-plays like Plug Power and Nel & Co. are struggling to get their numbers in order and are far from profitable business models. As a result, these shares are not much fun at the moment, and analysts see further downside potential. In such a situation, it is worth taking a look at other megatrend stocks. Redcare Pharmacy (formerly Shop Apotheke) is benefiting from online pharmacy and e-prescription trends. The share has already more than doubled this year. Investors can profit from the cannabis trend with the German Cantourage Group. The Company is growing strongly and the share price has come to rest (before the storm). Both shares are recommended to buy by analysts.
ReadCommented by André Will-Laudien on August 23rd, 2023 | 07:00 CEST
Climate change or just a heat wave? - BioNTech, Cardiol Therapeutics, and Redcare Pharmacy deliver!
Whether this consistently warm summer already documents a pronounced climate change is questionable. The older ones among us remember that there were already very hot summers before and that even in the last 30 years, there was rarely snow at Christmas. However, human life is simply too short for significant conclusions. Therefore, long-term weather records have to be consulted. There will probably be a slight increase in average temperatures, but we will get little information about when the next ice age will hit us. For many politicians, the current weather trends fit perfectly into the chain of arguments in favor of radical legislative proposals. Perhaps, however, the caprices of the weather are only the offshoots of the approaching El Nino. The stock market also follows changing trends; after the flood, an ebb could now be imminent. Selection remains key!
ReadCommented by Nico Popp on July 11th, 2023 | 07:30 CEST
Returns thanks to e-prescription and co.: Redcare Pharmacy, BB Biotech, Cardiol Therapeutics
There are attractive returns to be had in the healthcare sector. Innovative approaches around data and biotechnology are particularly promising, according to Daniel Matviyenko, Portfolio Manager of Healthcare Strategies at Jennison Associates. But what does this innovation look like in concrete terms? And how can investors invest? We highlight the healthcare industry using three companies as examples, with a special focus on opportunities in select individual stocks.
ReadCommented by Stefan Feulner on April 12th, 2023 | 10:23 CEST
Stocks in rally mode - Shop Apotheke, Tocvan Ventures, MicroStrategy
Despite the uncertainties concerning geopolitics and the continuing danger of a recession, the stock markets continue to run smoothly. Germany's leading index, the DAX, is close to a new high for the year at 15,650 points and is chasing the historic high of 16,299.50 points. Bitcoin, at over USD 30,000, and gold, at over USD 2,000 per ounce, have also cleared important hurdles. The signs are pointing to a rally in several asset classes.
ReadCommented by Juliane Zielonka on March 9th, 2023 | 10:54 CET
Aspermont, Amazon, Shop Apotheke - These shares embrace digitization!
Companies like the Canadian media company Aspermont are among the pioneers of digitization and are thus miles ahead of their competitors. With their unique platform solution, the original mining trade magazine publisher can quickly scale into other segments and keep both industry and experts up to date with the latest knowledge. The value of successful digitization is also evident in the Shop Apotheke business figures now published. The digital mail-order pharmacy, which is accessible in Europe, is able to score points despite a change in the management board. In the US, Amazon is one step further, launching 24/7 digital patient care operations through One Medical.
ReadCommented by Mario Hose on May 14th, 2020 | 13:11 CEST
BioNTech, EXMceuticals, Shop Apotheke Europe, Symrise - Shares gaining momentum
The easing of measures to contain the Corona Pandemic will be further extended and, in parallel, companies and their employees will be able to increase personal communications again. However, the curfew phase was also used for strategic decisions and developments, as investors can see from announcements in recent weeks. The situation represents a crisis for many people, but it is also an opportunity for change and a new beginning. Market participants have learned in recent months that dependence on China leads to many bottlenecks and global diversification is therefore necessary. Anyone who wants to be part of it must have the right shares in their portfolio.
Read